ICON Plc ICLR

DUBLIN, August 06, 2026--ICON Announces Pricing of USD 2.15 Billion Notes

ICON and Anthropic announced a multi year collaboration to integrate AI across the clinical trial lifecycle. The partnership is expected to touch areas such as protocol design, site selection, predictive analytics and ecosystem integration. The move aligns with ICON's broader digital and AI plans within the life sciences sector. ICON, traded as NasdaqGS:ICLR, is moving ahead with this collaboration while its share price stands at $156.85. The stock has seen declines of 13.0% over the past...

Greenskeeper Asset Management, an independent firm that specializes in disciplined value investing, recently released its Q2 2026 scorecard. A copy is available to download here. After a slow start to the year, the Fund gained 10.9% in the quarter, lifting its year-to-date return to 1.9%. The rebound came as markets showed signs of rotating away from momentum […]

DUBLIN, August 04, 2026--ICON Announces Private Offering of Notes

DUBLIN, July 31, 2026--ICON Announces Results of Annual General Meeting

Icon PLC (ICLR) reports robust $3.7 billion in gross business wins and a 1.51x book-to-bill ratio, but faces headwinds from elevated pass-through activity impacting gross margins.

DUBLIN, July 29, 2026--ICON Reports Second Quarter 2026 Results

Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark U.S. Concentrated Strategy”. A copy of the letter can be downloaded here. The strategy returned 9.21% (net) in the second quarter, lagging the Russell 1000 Value Index’s 13.87%. U.S. equities finished higher during the quarter, with nine of eleven GICS sectors posting gains, led […]